Vilnius University, Faculty of Medicine, Vilnius, Lithuania.
1Vilnius University, Faculty of Medicine, Vilnius, Lithuania; 2Vilnius University Hospital Santaros Klinikos, Lithuania.
Acta Biochim Pol. 2021 Dec 14;69(1):119-122. doi: 10.18388/abp.2020_5760.
Gaucher disease is one of the most common inherited lysosomal storage diseases caused by the deficiency of the enzyme β-glucocerebrosidase, leading to the accumulation of glucocerebroside. Depending on the clinical manifestations, two different forms of the disease are distinguished - the non-neuronopathic form (type 1) with a variety of presentations - from asymptomatic to symptomatic patients (characterized by hepatosplenomegaly, thrombocytopenia, anemia and osteopenia), and the neuronopathic form (known as types 2 and 3). Besides visceral, osseous, and hematopoietic organ lesions, neuronopathic forms are associated with central nervous system involvement (bulbar and pyramidal signs, horizontal saccadic eye movements, myoclonic epilepsy, progressive development delay). In type 2, the neurological symptoms appear earlier and are more severe, the survival time is shorter. In type 3, the neurological symptoms are milder and allow patients to live a fully productive life.
This article includes a review of two cases of neuronopathic Gaucher disease: type 2 and severe type 3. Both patients presented symptoms during infancy and the manifestations were similar but varied in intensity and the dynamics of progress. Enzyme replacement therapy was started in both cases, which decreased visceral symptoms.
Both described cases indicate the lack of knowledge and the tendency of doctors to disregard the possibility of Gaucher disease in their paediatrics patients.
戈谢病是最常见的遗传性溶酶体贮积病之一,由β-葡糖脑苷脂酶缺乏引起,导致葡糖脑苷脂堆积。根据临床表现,该病分为两种不同形式——非神经病变型(1 型),表现多样——从无症状到有症状患者(特征为肝脾肿大、血小板减少、贫血和骨质疏松症),以及神经病变型(称为 2 型和 3 型)。除内脏、骨骼和造血器官损伤外,神经病变型还与中枢神经系统受累有关(球部和锥体征、水平扫视眼运动、肌阵挛性癫痫、进行性发育迟缓)。在 2 型中,神经症状出现较早且更为严重,存活时间较短。在 3 型中,神经症状较轻,患者可过完全有生产力的生活。
本文包括两例神经病变型戈谢病病例:2 型和重型 3 型。这两名患者均在婴儿期出现症状,表现相似但强度和进展速度不同。两种情况下均开始了酶替代治疗,减少了内脏症状。
所描述的两种情况表明,医生缺乏相关知识,且倾向于忽视戈谢病在儿科患者中的可能性。